T
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Price:
16.25 USD
1.56%
Market Closed
Updated:
May 11, 2024
Balance Sheet
Balance Sheet Decomposition
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
| Current Assets | 12.5B |
| Cash & Short-Term Investments | 3.2B |
| Receivables | 3.4B |
| Other Current Assets | 5.9B |
| Non-Current Assets | 31B |
| PP&E | 6.1B |
| Intangibles | 22.6B |
| Other Non-Current Assets | 2.3B |
| Current Liabilities | 12.2B |
| Accounts Payable | 2.6B |
| Accrued Liabilities | 3.4B |
| Short-Term Debt | 23m |
| Other Current Liabilities | 6.2B |
| Non-Current Liabilities | 23.7B |
| Long-Term Debt | 18.2B |
| Other Non-Current Liabilities | 5.6B |
Balance Sheet
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2 226
|
6 946
|
988
|
963
|
1 782
|
1 975
|
2 177
|
2 165
|
2 801
|
3 226
|
|
| Cash Equivalents |
2 226
|
6 946
|
988
|
963
|
1 782
|
1 975
|
2 177
|
2 165
|
2 801
|
3 226
|
|
| Short-Term Investments |
0
|
11
|
679
|
14
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5 408
|
5 350
|
7 523
|
7 128
|
5 822
|
5 676
|
4 581
|
4 529
|
3 696
|
3 408
|
|
| Accounts Receivables |
5 408
|
5 350
|
7 523
|
7 128
|
5 822
|
5 676
|
4 581
|
4 529
|
3 696
|
3 408
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
4 371
|
3 966
|
4 954
|
4 924
|
4 731
|
4 422
|
4 403
|
3 818
|
3 833
|
4 022
|
|
| Other Current Assets |
2 391
|
2 125
|
3 084
|
2 353
|
1 457
|
1 391
|
1 844
|
2 061
|
1 721
|
1 830
|
|
| Total Current Assets |
14 396
|
18 398
|
17 228
|
15 382
|
13 794
|
13 464
|
13 005
|
12 573
|
12 051
|
12 486
|
|
| PP&E Net |
6 535
|
6 544
|
8 073
|
7 673
|
6 868
|
6 950
|
6 855
|
6 477
|
6 158
|
6 147
|
|
| PP&E Gross |
6 535
|
6 544
|
8 073
|
7 673
|
6 868
|
6 950
|
6 855
|
6 477
|
6 158
|
6 147
|
|
| Accumulated Depreciation |
3 345
|
3 529
|
3 853
|
4 505
|
4 928
|
4 914
|
5 092
|
5 241
|
5 518
|
5 637
|
|
| Intangible Assets |
5 512
|
7 675
|
21 487
|
17 640
|
14 005
|
11 232
|
8 923
|
7 466
|
6 270
|
5 387
|
|
| Goodwill |
18 408
|
19 025
|
44 409
|
28 414
|
24 917
|
24 846
|
20 624
|
20 040
|
17 633
|
17 177
|
|
| Long-Term Investments |
0
|
0
|
0
|
83
|
61
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1 569
|
2 591
|
1 860
|
1 423
|
1 038
|
978
|
1 233
|
1 110
|
1 899
|
2 283
|
|
| Other Assets |
18 408
|
19 025
|
44 409
|
28 414
|
24 917
|
24 846
|
20 624
|
20 040
|
17 633
|
17 177
|
|
| Total Assets |
46 420
N/A
|
54 233
+17%
|
93 057
+72%
|
70 615
-24%
|
60 683
-14%
|
57 470
-5%
|
50 640
-12%
|
47 666
-6%
|
44 011
-8%
|
43 480
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 171
|
1 918
|
2 157
|
2 069
|
1 853
|
1 718
|
1 756
|
1 686
|
1 887
|
2 602
|
|
| Accrued Liabilities |
0
|
2 391
|
4 264
|
3 563
|
2 738
|
2 680
|
2 581
|
2 880
|
2 810
|
3 479
|
|
| Short-Term Debt |
0
|
596
|
2 466
|
766
|
516
|
514
|
514
|
23
|
23
|
23
|
|
| Current Portion of Long-Term Debt |
1 761
|
989
|
810
|
2 880
|
1 700
|
1 831
|
2 674
|
1 403
|
2 086
|
1 649
|
|
| Other Current Liabilities |
7 357
|
7 111
|
8 791
|
8 643
|
7 515
|
6 931
|
5 639
|
5 035
|
4 663
|
4 494
|
|
| Total Current Liabilities |
12 289
|
13 005
|
18 488
|
17 921
|
14 322
|
13 674
|
13 164
|
11 027
|
11 469
|
12 247
|
|
| Long-Term Debt |
8 523
|
8 347
|
32 522
|
28 827
|
26 691
|
24 562
|
22 731
|
21 617
|
19 103
|
18 161
|
|
| Deferred Income Tax |
1 101
|
1 748
|
5 413
|
3 277
|
2 140
|
1 096
|
964
|
784
|
548
|
606
|
|
| Minority Interest |
42
|
158
|
1 656
|
1 386
|
1 087
|
1 091
|
1 035
|
966
|
794
|
620
|
|
| Other Liabilities |
1 152
|
1 206
|
1 641
|
1 845
|
1 736
|
3 075
|
2 720
|
2 994
|
4 293
|
4 339
|
|
| Total Liabilities |
23 107
N/A
|
24 464
+6%
|
59 720
+144%
|
53 256
-11%
|
45 976
-14%
|
43 498
-5%
|
40 614
-7%
|
37 388
-8%
|
36 207
-3%
|
35 973
-1%
|
|
| Equity | |||||||||||
| Common Stock |
50
|
3 343
|
3 674
|
3 685
|
56
|
56
|
57
|
57
|
57
|
57
|
|
| Retained Earnings |
14 436
|
14 851
|
13 607
|
3 803
|
5 958
|
6 956
|
10 946
|
10 529
|
12 975
|
13 534
|
|
| Additional Paid In Capital |
14 121
|
17 757
|
23 409
|
23 479
|
27 210
|
27 312
|
27 443
|
27 561
|
27 688
|
27 807
|
|
| Unrealized Security Profit/Loss |
93
|
312
|
7
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
3 951
|
4 227
|
4 194
|
4 149
|
4 142
|
4 128
|
4 128
|
4 128
|
4 128
|
4 128
|
|
| Other Equity |
1 250
|
2 267
|
3 152
|
1 849
|
2 460
|
2 312
|
2 400
|
2 683
|
2 838
|
2 696
|
|
| Total Equity |
23 313
N/A
|
29 769
+28%
|
33 337
+12%
|
17 359
-48%
|
14 707
-15%
|
13 972
-5%
|
10 026
-28%
|
10 278
+3%
|
7 804
-24%
|
7 506
-4%
|
|
| Total Liabilities & Equity |
46 420
N/A
|
54 233
+17%
|
93 057
+72%
|
70 615
-24%
|
60 683
-14%
|
57 470
-5%
|
50 640
-12%
|
47 666
-6%
|
44 011
-8%
|
43 479
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
852
|
908
|
1 015
|
1 017
|
1 089
|
1 092
|
1 097
|
1 103
|
1 121
|
1 121
|
|
| Preferred Shares Outstanding |
0
|
3
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
